1. Home
  2. Labeler Index
  3. Exela Pharma Sciences, Llc
  4. 51754-5012
  5. NDC Package Code: 51754-5012-4 Sodium Bicarbonate

NDC Package 51754-5012-4 Sodium Bicarbonate

Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51754-5012-4
Package Description:
25 VIAL in 1 CARTON / 10 mL in 1 VIAL
Product Code:
51754-5012
Proprietary Name:
Sodium Bicarbonate
Non-Proprietary Name:
Sodium Bicarbonate
Substance Name:
Sodium Bicarbonate
Usage Information:
Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate.Treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis - e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. But since an appreciable time interval may elapse before all of the ancillary effects are brought about, bicarbonate therapy is indicated to minimize risks inherent to the acidosis itself.Vigorous bicarbonate therapy is required in any form of metabolic acidosis where a rapid increase in plasma total CO2 content is crucial - e.g., cardiac arrest, circulatory insufficiency due to shock or severe dehydration, and in severe primary lactic acidosis or severe diabetic acidosis.
11-Digit NDC Billing Format:
51754501204
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1868486 - sodium bicarbonate 8.4 % (50 MEQ) in 50 ML Injection
  • RxCUI: 1868486 - 50 ML sodium bicarbonate 84 MG/ML Injection
  • RxCUI: 1868486 - 50 ML NaHCO3 84 MG/ML Injection
  • RxCUI: 1868486 - sodium bicarbonate 8.4 % (50 MEQ) per 50 ML Injection
  • RxCUI: 1923484 - sodium bicarbonate 8.4 % (10 MEQ) in 10 mL Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Exela Pharma Sciences, Llc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • SODIUM BICARBONATE 42 mg/mL
    • Pharmacologic Class(es):
  • Alkalinizing Activity - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA211091
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    09-27-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51754-5012-4?

    The NDC Packaged Code 51754-5012-4 is assigned to a package of 25 vial in 1 carton / 10 ml in 1 vial of Sodium Bicarbonate, a human prescription drug labeled by Exela Pharma Sciences, Llc. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 51754-5012 included in the NDC Directory?

    Yes, Sodium Bicarbonate with product code 51754-5012 is active and included in the NDC Directory. The product was first marketed by Exela Pharma Sciences, Llc on September 27, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 51754-5012-4?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 51754-5012-4?

    The 11-digit format is 51754501204. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151754-5012-45-4-251754-5012-04